Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma

MicroRNAs as markers to monitor Endothelin-1 signaling and potential treatment in renal disease: Carcinoma - proteinuric damage - toxicity. (review)

(2019) J. W. U. Fries   BIOLOGY OF THE CELL

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas

(2019) Ivana Jovčevska et al.   Cancers

Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma

(2019) Lynda Vuong et al.   Cancer Discovery

Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis

(2019) Haisheng Yang et al.   GENE

Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney

(2018) Mohammed Akhtar et al.   ADVANCES IN ANATOMIC PATHOLOGY

Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling

(2018) Hongchao He et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial

(2018) Toni K Choueiri et al.   LANCET ONCOLOGY

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma

(2018) Jing Zhang et al.   SCIENCE

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

(2018) Diana Miao et al.   SCIENCE

Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma

(2018) Yue Pan et al.   HEREDITAS

Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma

(2018) Sarah E. Arthur et al.   Nature Communications

Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy

(2018) Youcef Rustum et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau

(2018) Mickael Audrain et al.   MOLECULAR PSYCHIATRY

Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation

(2017) Aristotle Bamias et al.   ONCOLOGIST

Downregulation ofWDR20due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma

(2016) Mika Takahashi et al.   CANCER SCIENCE

Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell Carcinoma

(2016) Martin H. Voss et al.   JOURNAL OF CLINICAL ONCOLOGY

TYROBP genetic variants in early-onset Alzheimer's disease

(2016) Cyril Pottier et al.   NEUROBIOLOGY OF AGING

Bioinformatic profiling identifies an immune-related risk signature for glioblastoma

(2016) Wen Cheng et al.   NEUROLOGY

Characterization of clear cell renal cell carcinoma by gene expression profiling

(2016) Bryan J. Thibodeau et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis

(2015) Stefanie Meister et al.   RHEUMATOLOGY INTERNATIONAL

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Correction: Structural Characterization of the Complex of SecB and Metallothionein-Labeled proOmpA by Cryo-Electron Microscopy

(2013) Qiang Zhou et al.   PLoS One

NCBI GEO: archive for functional genomics data sets—update

(2012) Tanya Barrett et al.   NUCLEIC ACIDS RESEARCH

Current and future systemic treatments for renal cell carcinoma

(2012) Rosalie Fisher et al.   SEMINARS IN CANCER BIOLOGY

Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease

(2011) Sadeep Shrestha et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

(2011) Christian M. Metallo et al.   NATURE

Cytoscape 2.8: new features for data integration and network visualization

(2010) M. E. Smoot et al.   BIOINFORMATICS

A defunctioning polymorphism inFCGR2Bis associated with protection against malaria but susceptibility to systemic lupus erythematosus

(2010) Lisa C. Willcocks et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FCGR2B gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese

(2009) X.-j. Zhou et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION